drugset

drugset / Trial / NCT01820832

Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD

NCT01820832 ↗

Phase 4 Unknown 60 enrolled Huashan Hospital

RandomizedParallel-groupOpen-labelTreatment

Summary

The safety and efficacy of Caltriol on mild proteinuria (\<1.0g/d) reduction in CKD patients.

Timeline

Start: 2013-03
Primary completion: 2014-12
Completion: 2015-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Calcitriol	Small molecule	0.5 ug	Oral

Indications